LicianPro

PDSB stock

PDS Biotechnology Corp (PDSB) short interest & short volume · 3.4M shares short

PDS Biotechnology Corp official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

PDSB short interest rose 22.3% to 3.4M shares in the Oct 15, 2026 report (1.0 days to cover). Daily short volume averaged 43.2% of volume over the last 20 sessions, down from 51.6% the 20 sessions before, the 21st percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
3.4M
prior 2.8M
% of float
—
no float on file
Days to cover
1.0
avg vol 16.4M
Change vs prior report
+22.3%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
29.3%
707K of 2.4M
20-day average
43.2%
prior 51.6%
Percentile vs own history
21st
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: +8.5%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

PDSB's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · PDSB overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-02707,1422,414,13129.3%
2026-10-30644,3503,142,25520.5%
2026-10-291,993,3504,807,17041.5%
2026-10-285,334,03610,470,54950.9%
2026-10-274,507,6147,649,82258.9%
2026-10-26405,0281,384,66129.3%
2026-10-23881,6771,729,74451.0%
2026-10-221,540,5853,187,90148.3%
2026-10-215,940,41310,778,38355.1%
2026-10-20998,9412,388,71041.8%

Healthcare peers with similar quant ratings

PDSB among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

PDSB short interest FAQ

What is PDSB's short interest?

PDS Biotechnology Corp (PDSB) had 3.4M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.

How many days to cover does PDSB have?

1.0 days: 3.4M shares short divided by an average daily volume of 16.4M for the Oct 15, 2026 period.

Is PDSB short interest rising or falling?

PDSB short interest rose (+22.3%) from 2.8M to 3.4M shares in the Oct 15, 2026 report.

Is PDSB a short squeeze candidate?

Lician's squeeze watch scores PDSB 16 out of 100 (low) from the Oct 15, 2026 report: days to cover 2.5/25, change in short interest vs prior report 6.7/15, price change since settlement date 6.8/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of PDSB daily volume is sold short?

43.2% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 21st percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was PDSB's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for PDS Biotechnology Corp (PDSB) was 707,142 shares, 29.3% of 2,414,131 total volume.

How many PDSB short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for PDS Biotechnology Corp (PDSB), from Oct 20, 2026 through Nov 2, 2026.

How did PDSB short volume percent change from the prior cached session?

Cached FINRA short volume for PDS Biotechnology Corp (PDSB) moved from 20.5% on Oct 30, 2026 to 29.3% on Nov 2, 2026, up 8.8 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.